About our Scientific Partners
The XCell-Center collaborates with referring hospitals and physicians from around the world.
Many patients are referred by their physicians, while others contact us directly. Our patients are treated comfortably in a professional and caring environment. Word of mouth is our highest priority and patients frequently return for a second or third treatment.
To best serve out patients, we continually update our results and invest substantially in the latest medical equipment.
The XCell-Center combines clinical expertise with scientific research.
For 2009 - 2010, we plan to initiate two international clinical trials, one for Spinal Cord Injury and the other for Cerebral Palsy.
In 2009, we've commenced a study in cooperation with the University of Crete: "Stem Cells in Diabetes Mellitus Patients with Limb Amputation".
In addition to clinical trials, we also perform pre-clinical research projects
These projects involve second and third generation stem cells. Second generation stem cells will enable us to multiply mesenchymal cells (multiple treatment option). Third generation stem cells will allow us to target specific cells (multiplied targeted progenitor cells, f.e. progenitor neuro-cells).
These projects are developing in close collaboration with Neuronax and the University of Clermont Ferrand in France.
Scientific and Medical Advisory Board
The XCell-Center's Scientific and Medical Advisory board includes experts from all over the world:
- Prof. Dr. Dr.h.c. Nils Haberland,
neurosurgeon, Cairo (Egypt) & Hannover (Germany) - Dr. Michael G. Muhonen, M.D.,
- pediatric neurosurgeon, Orange County (CA, USA)
- Dr. William Loudon M.D., Ph.D.,
pediatric neurosurgeon, Orange County (CA, USA)
